Results 201 to 210 of about 131,391 (240)
Some of the next articles are maybe not open access.
Junction of the Epidermis and Dermis
Nature, 1958AT the surface of the dermis, fine fibres form a continuous subepithelial network1. These fibres, unlike the underlying coarser fibres, are argyrophilic and also stain red with periodic acid–Schiff technique2 (Hotchkiss's method3). Into this network, processes from the basal epidermal cells project, and it has been reported that the interlocking of ...
openaire +2 more sources
2012
Chapter 5 covers Collagen disorders (Ainhum, Amniotic Bands, Buschke-Ollendorff Syndrome, Dermatosparaxis), Ehlers-Danlos Syndromes (Ehlers-Danlos Types I, II, and III, Ehlers-Danlos Type IV, Ehlers-Danlos Type VI, Ehlers-Danlos Type VIII, and Reactive Perforating Collagenosis), Elastin (Costello Syndrome, Cutis Laxa, and Pseudoxanthoma Elasticum ...
openaire +1 more source
Chapter 5 covers Collagen disorders (Ainhum, Amniotic Bands, Buschke-Ollendorff Syndrome, Dermatosparaxis), Ehlers-Danlos Syndromes (Ehlers-Danlos Types I, II, and III, Ehlers-Danlos Type IV, Ehlers-Danlos Type VI, Ehlers-Danlos Type VIII, and Reactive Perforating Collagenosis), Elastin (Costello Syndrome, Cutis Laxa, and Pseudoxanthoma Elasticum ...
openaire +1 more source
1983
Although to a great extent the epidermal cells control their own fate through their chalone control mechanism, it is clear that they are also dependent in many ways on influences emanating from the dermis. In adult epidermis the chalone mechanism cannot function without the promitotic action of the mesenchymal factor, and the regional differences in ...
openaire +1 more source
Although to a great extent the epidermal cells control their own fate through their chalone control mechanism, it is clear that they are also dependent in many ways on influences emanating from the dermis. In adult epidermis the chalone mechanism cannot function without the promitotic action of the mesenchymal factor, and the regional differences in ...
openaire +1 more source
The Human Dermis as a Target of Nanoparticles for Treating Skin Conditions
Pharmaceutics, 2023Vilos C +2 more
exaly